CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Tilray reaffirms FY2027 adjusted EBITDA guidance of $68M-$75M while integrating BrewDog and preparing for Carlsberg deal

EarningsNeutral
AI Analysis

Summary

Tilray reaffirmed its FY2027 adjusted EBITDA guidance of $68M-$75M while proceeding with the integration of BrewDog and preparing for a deal with Carlsberg.

Financial Highlights

Guidance

$68M-$75M adjusted EBITDA for FY2027

Importance:3/10
Sentiment:
0.00
guidanceEBITDAM&AintegrationCarlsberg deal
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 8, 2026 6:04 PM

Read Original